Jul 29
|
Wall Street is still jittery on GLP-1s
|
Jul 29
|
Should We Be Delighted With Amgen Inc.'s (NASDAQ:AMGN) ROE Of 75%?
|
Jul 29
|
NewAmsterdam heart drug hits trial goal, but data appear to disappoint investors
|
Jul 25
|
Amgen (AMGN) Stock Moves -0.39%: What You Should Know
|
Jul 25
|
Amgen Surges As Weight-Loss Trials Drive Excitement
|
Jul 24
|
What Lies in Store for Healthcare ETFs in Q2 Earnings?
|
Jul 23
|
7 Biotech Stocks to Keep on Your Clinical Radar
|
Jul 23
|
3 Stocks That Are Melting Up. Is There Room to Run?
|
Jul 23
|
Investors in Amgen (NASDAQ:AMGN) have seen splendid returns of 122% over the past five years
|
Jul 23
|
Nanotechnology in medicine: Who are the leading public companies?
|
Jul 22
|
Dow Jones Leader Amgen, Nvidia Stock, Coinbase In Or Near Buy Zones
|
Jul 22
|
Beat the Market Like Zacks: Karooooo, UnitedHealth, Amgen in Focus
|
Jul 22
|
Pipeline Moves: Novo Nordisk progression prospects drop after candidate terminated
|
Jul 14
|
3 Dividend Growth Stocks to Buy and Hold
|
Jul 13
|
Amgen Inc.'s (NASDAQ:AMGN) high institutional ownership speaks for itself as stock continues to impress, up 6.4% over last week
|
Jul 12
|
Amgen (AMGN) Rises Higher Than Market: Key Facts
|
Jul 12
|
Amgen’s Imdelltra BiTEs into SCLC treatment drought
|
Jul 9
|
Study Shows Lilly's (LLY) Obesity Drug More Effective Than NVO's
|
Jul 9
|
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
|
Jul 9
|
Amgen Inc. (AMGN): Hedge Funds Are Bullish on This Blue Chip Dividend Stock Now
|